Form 13G’s must be filed with the SEC upon any investor or entity amassing at least 5% of a company’s outstanding shares, or alternatively, an investment falling beneath the 5% ownership threshold. Investors should closely monitor this filing activity, as it represents the trading activity of some of the company’s biggest supporters, who have doubtlessly done an immense amount of research on the company and its sector and have a good understanding of its value and potential. Below we have embedded just such a filing, issued by James Flynn‘s Deerfield Management on Editas Medicine Inc (NASDAQ:EDIT), which had its IPO earlier this month and which has 5.07% of its shares owned by Deerfield now.
You can access the original SEC filing by clicking here.
Ownership Summary Table
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Deerfield Mgmt HIF, | 0 | 854,700 | 0 | 854,700 | 854,700 | 2.39% |
| Deerfield Management Company, | 0 | 1,809,400 | 0 | 1,809,400 | 1,809,400 | 5.07% |
| Deerfield Mgmt III, | 0 | 954,700 | 0 | 954,700 | 954,700 | 2.67% |
| Deerfield Healthcare Innovations Fund, | 0 | 854,700 | 0 | 854,700 | 854,700 | 2.39% |
Follow James E. Flynn's Deerfield Management
Page 1 of 13 SEC Filing
Editas Medicine, Inc.
Common Stock, $0.0001 par value per share
28106W103
February 2, 2016
